Metabolic Tumor Volume Response Assessment Using (11)C-Methionine Positron Emission Tomography Identifies Glioblastoma Tumor Subregions That Predict Progression Better Than Baseline or Anatomic Magnetic Resonance Imaging Alone

Stupp, 2005, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, 352, 987, 10.1056/NEJMoa043330 Stupp, 2017, Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: A randomized clinical trial, JAMA, 318, 2306, 10.1001/jama.2017.18718 Chang, 2007, Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma, Int J Radiat Oncol Biol Phys, 68, 144, 10.1016/j.ijrobp.2006.12.009 Macdonald, 1990, Response criteria for phase II studies of supratentorial malignant glioma, J Clin Oncol, 8, 1277, 10.1200/JCO.1990.8.7.1277 Autry, 2017, Characterization of metabolic, diffusion, and perfusion properties in gbm: Contrast-enhancing versus non-enhancing tumor, Transl Oncol, 10, 895, 10.1016/j.tranon.2017.08.009 Grosu, 2005, L-(methyl-11c) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy, Int J Radiat Oncol Biol Phys, 63, 64, 10.1016/j.ijrobp.2005.01.045 Pirotte, 2006, Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: A report of 103 consecutive procedures, J Neurosurg, 104, 238, 10.3171/jns.2006.104.2.238 Heiss, 2014, Pet in gliomas. Overview of current studies, Nuklearmedizin, 53, 163 Pirotte, 2009, Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: A survival analysis in 66 consecutive patients, Neurosurgery, 64, 471, 10.1227/01.NEU.0000338949.94496.85 Barajas, 2012, Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR imaging, Neuro Oncol, 14, 942, 10.1093/neuonc/nos128 Di Costanzo, 2006, Multiparametric 3t MR approach to the assessment of cerebral gliomas: Tumor extent and malignancy, Neuroradiology, 48, 622, 10.1007/s00234-006-0102-3 McKnight, 2002, Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence, J Neurosurg, 97, 794, 10.3171/jns.2002.97.4.0794 Lee, 2009, Association of 11c-methionine pet uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme, Int J Radiat Oncol Biol Phys, 73, 479, 10.1016/j.ijrobp.2008.04.050 Albert, 2016, Response assessment in neuro-oncology working group and European association for neuro-oncology recommendations for the clinical use of PET imaging in gliomas, Neuro Oncol, 18, 1199, 10.1093/neuonc/now058 Omuro, 2006, Pitfalls in the diagnosis of brain tumours, Lancet Neurol, 5, 937, 10.1016/S1474-4422(06)70597-X Glaudemans, 2013, Value of 11c-methionine PET in imaging brain tumours and metastases, Eur J Nucl Med Mol Imaging, 40, 615, 10.1007/s00259-012-2295-5 Bergstrom, 1987, Comparison of the accumulation kinetics of l-(methyl-11c)-methionine and d-(methyl-11c)-methionine in brain tumors studied with positron emission tomography, Acta Radiol, 28, 225 Langen, 2000, Transport mechanisms of 3-[123i]iodo-alpha-methyl-l-tyrosine in a human glioma cell line: Comparison with [3h]methyl]-l-methionine, J Nucl Med, 41, 1250 Okubo, 2010, Correlation of l-methyl-11c-methionine (met) uptake with l-type amino acid transporter 1 in human gliomas, J Neurooncol, 99, 217, 10.1007/s11060-010-0117-9 Upadhyay, 2011, Conventional MRI evaluation of gliomas, Br J Radiol, 84 Spec, S107, 10.1259/bjr/65711810 Kim, 2018, Prognostic value of the metabolic and volumetric parameters of (11)c-methionine positron-emission tomography for gliomas: A systematic review and meta-analysis, Am J Neuroradiol, 39, 1629, 10.3174/ajnr.A5707 Boellaard, 2004, Effects of noise, image resolution, and roi definition on the accuracy of standard uptake values: A simulation study, J Nucl Med, 45, 1519 Tsien, 2012, Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma, Clin Cancer Res, 18, 273, 10.1158/1078-0432.CCR-11-2073 Brix, 1997, Performance evaluation of a whole-body PET scanner using the nema protocol. National Electrical Manufacturers Association, J Nucl Med, 38, 1614 Cao Y. We-d-t-6c-03: Development of image software tools for radiation therapy assessment. Medical Physics 2005;32:2136. Torii, 2005, Correlation of amino-acid uptake using methionine pet and histological classifications in various gliomas, Ann Nucl Med, 19, 677, 10.1007/BF02985116 Benjamini, 1995, Controlling the false discovery rate: A practical and powerful approach to multiple testing, J R Stat Soc Series B Stat Methodol, 57, 289 Wen, 2010, Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group, J Clin Oncol, 28, 1963, 10.1200/JCO.2009.26.3541 Vogelbaum, 2009, End point assessment in gliomas: Novel treatments limit usefulness of classical MacDonald's criteria, J Clin Oncol, 27, 2905, 10.1200/JCO.2009.22.4998 Galldiks, 2012, Assessment of treatment response in patients with glioblastoma using o-(2-18f-fluoroethyl)-l-tyrosine PET in comparison to MRI, J Nucl Med, 53, 1048, 10.2967/jnumed.111.098590 Galldiks, 2006, Use of 11c-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas, Eur J Nucl Med Mol Imaging, 33, 516, 10.1007/s00259-005-0002-5 Beppu, 2016, MRI and 11c-methyl-l-methionine PET differentiate bevacizumab true responders after initiating therapy for recurrent glioblastoma, Clin Nucl Med, 41, 852, 10.1097/RLU.0000000000001377 Schwarzenberg, 2014, Treatment response evaluation using 18f-fdopa PET in patients with recurrent malignant glioma on bevacizumab therapy, Clin Cancer Res, 20, 3550, 10.1158/1078-0432.CCR-13-1440 Hutterer, 2011, O-(2-18f-fluoroethyl)-l-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma, J Nucl Med, 52, 856, 10.2967/jnumed.110.086645 Galldiks, 2013, Response assessment of bevacizumab in patients with recurrent malignant glioma using [18f]fluoroethyl-l-tyrosine PET in comparison to MRI, Eur J Nucl Med Mol Imaging, 40, 22, 10.1007/s00259-012-2251-4 Moffat, 2005, Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response, Proc Natl Acad Sci USA, 102, 5524, 10.1073/pnas.0501532102 Tsien, 2010, Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma, J Clin Oncol, 28, 2293, 10.1200/JCO.2009.25.3971 Galbán, 2009, The parametric response map is an imaging biomarker for early cancer treatment outcome, Nat Med, 15, 572, 10.1038/nm.1919 Cao, 2006, Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected], Int J Radiat Oncol Biol Phys, 64, 876, 10.1016/j.ijrobp.2005.09.001 Galban, 2015, Development of a multiparametric voxel-based magnetic resonance imaging biomarker for early cancer therapeutic response assessment, Tomography, 1, 44, 10.18383/j.tom.2015.00124 Lohmann, 2019, Combined amino acid positron emission tomography and advanced magnetic resonance imaging in glioma patients, Cancers, 11, 153, 10.3390/cancers11020153 Galldiks, 2012, Volumetry of [11c]-methionine positron emission tomographic uptake as a prognostic marker before treatment of patients with malignant glioma, Mol Imaging, 11, 516, 10.2310/7290.2012.00022 Yoo, 2015, Prognostic value of metabolic tumor volume on (11)c-methionine pet in predicting progression-free survival in high-grade glioma, Nucl Med Mol Imaging, 49, 291, 10.1007/s13139-015-0362-0 Kim, 2019, Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma, J Neuro Oncol, 143, 313, 10.1007/s11060-019-03166-3 Kim, 2019, Developing a pipeline for multiparametric MRI-guided radiation therapy: Initial results from a phase II clinical trial in newly diagnosed glioblastoma, Tomography, 5, 118, 10.18383/j.tom.2018.00035 Wang, 2018, C11 methionine PET (MET-PET) imaging of glioblastoma for detecting postoperative residual disease and response to chemoradiation therapy, Int J Radiat Oncol Biol Phys, 102, 1024, 10.1016/j.ijrobp.2018.06.011